BIOMAT Database Logo BIOMAT Database Logo

Phage therapy: an attractive option for dealing with antibiotic-resistant bacterial infections. 2005

Alexander Sulakvelidze

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases
D001433 Bacteriolysis Rupture of bacterial cells due to mechanical force, chemical action, or the lytic growth of BACTERIOPHAGES. Bacteriolyses
D001435 Bacteriophages Viruses whose hosts are bacterial cells. Phages,Bacteriophage,Phage
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance

Related Publications

Alexander Sulakvelidze
Phage Therapy for Antibiotic-Resistant Bacterial Infections.
January 2022, Annual review of medicine,
Alexander Sulakvelidze
Antibiotic Therapy Duration for Multidrug-Resistant Gram-Negative Bacterial Infections: An Evidence-Based Review.
July 2025, International journal of molecular sciences,
Alexander Sulakvelidze
Phage therapy for secondary bacterial infections with COVID-19.
February 2022, Current opinion in virology,
Alexander Sulakvelidze
Targeting antibiotic resistant bacteria with phage reduces bacterial density in an insect host.
March 2019, Biology letters,
Alexander Sulakvelidze
Antibiotic therapy for severe bacterial infections.
September 2025, Intensive care medicine,
Alexander Sulakvelidze
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections.
January 2021, Nature reviews. Microbiology,
Alexander Sulakvelidze
Safety and effectiveness of home intravenous antibiotic therapy for multidrug-resistant bacterial infections.
June 2015, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Alexander Sulakvelidze
An ensemble method for prediction of phage-based therapy against bacterial infections.
January 2023, Frontiers in microbiology,
Alexander Sulakvelidze
Antibiotic therapy for pan-drug-resistant infections.
January 2022, Le infezioni in medicina,
Alexander Sulakvelidze
Collateral sensitivity: An evolutionary trade-off between antibiotic resistance mechanisms, attractive for dealing with drug-resistance crisis.
July 2023, Health science reports,
Copied contents to your clipboard!